First Time Loading...

Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 159.7 USD 0.81% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one ZTS stock under the Base Case scenario is 137.38 USD. Compared to the current market price of 159.7 USD, Zoetis Inc is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZTS Relative Value
Base Case
137.38 USD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.6
P/S
P/S
Price to Sales
8.6
vs History
87
vs Industry
17
Median 3Y
10.3
Median 5Y
10.1
Industry
2.4
Forward
7.9
More Details
31.2
P/E
P/E
Price to Earnings
31.2
vs History
96
vs Industry
15
Median 3Y
38.6
Median 5Y
39.9
Industry
22.9
Forward
27.3
More Details
31.1
P/OCF
P/OCF
Price to OCF
31.1
vs History
87
vs Industry
14
Median 3Y
38.6
Median 5Y
37.1
Industry
17.1
More Details
1 984.6
P/FCFE
P/FCFE
Price to FCFE
1 984.6
vs History
6
vs Industry
0
Median 3Y
74.5
Median 5Y
55.8
Industry
23.2
More Details
14.6
P/B
P/B
Price to Book Value
14.6
vs History
96
vs Industry
3
Median 3Y
17.8
Median 5Y
19.8
Industry
2.1
More Details
9.1
EV/S
EV/S
Enterprise Value to Sales
9.1
vs History
85
vs Industry
16
Median 3Y
10.8
Median 5Y
10.6
Industry
2.6
Forward
8.4
More Details
12.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.9
vs History
90
vs Industry
16
Median 3Y
15.3
Median 5Y
15.3
Industry
5.1
More Details
21.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.6
vs History
93
vs Industry
18
Median 3Y
25.7
Median 5Y
26
Industry
13.6
Forward
19.3
More Details
25
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25
vs History
95
vs Industry
18
Median 3Y
29.8
Median 5Y
30.6
Industry
17
Forward
22.1
More Details
33
EV/OCF
EV/OCF
Enterprise Value to OCF
33
vs History
87
vs Industry
14
Median 3Y
40.4
Median 5Y
38.7
Industry
15.8
More Details
48
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
48
vs History
73
vs Industry
11
Median 3Y
56.8
Median 5Y
52.8
Industry
17.6
More Details
6.6
EV/IC
EV/IC
Enterprise Value to IC
6.6
vs History
85
vs Industry
14
Median 3Y
7.8
Median 5Y
7.4
Industry
1.9
More Details

Multiples Across Competitors

ZTS Competitors Multiples
Zoetis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zoetis Inc
NYSE:ZTS
73.2B USD 8.6 31.2 21.6 25
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
699.9B USD 20.5 133.6 60.3 69.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 17 47.1 34.5 37.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
353.4B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
329.4B USD 5.5 902.5 44.8 87.6
UK
AstraZeneca PLC
LSE:AZN
186.4B GBP 5.1 39.3 140.6 225.6
CH
Novartis AG
SIX:NOVN
181.7B CHF 4.3 13.4 9.8 16.2
CH
Roche Holding AG
SIX:ROG
176.3B CHF 3 15.3 8.7 10.4

See Also

Summary
ZTS intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZTS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZTS stock valuation using valuation multiples.
Wall Street Estimates
ZTS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZTS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.